CoChat

Academy of Nutrition and Dietetics Gestational Diabetes Evidence-Based Nutrition Practice Guideline

Duarte-Gardea, Maria O., Gonzales-Pacheco, Diana M., Reader, Diane Marie, Thomas, Alyce M., Wang, Susan R., Gregory, Rebecca P., Piemonte, Tami A., Thompson, Kyle L., Moloney, Lisa · 2018 · Journal of the Academy of Nutrition and Dietetics
Cited by 110

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

G ESTATIONAL DIABETES MELlitus (GDM) is a common perinatal complication characterized by glucose intolerance that develops during pregnancy. The American Diabetes Association (ADA) defines GDM as “diabetes diagnosed in the second or third trimester of pregnancy that was not clearly overt diabetes prior to gestation.” The exact prevalence of GDM is unknown. In 2010, GDM prevalence in the United States was estimated to be 4.6% to 9.2%. However, not all experts agree on the criteria to diagnose GDM and the estimated incidence of GDM depends on the population, the diagnostic criteria used, and the source of the data. Over the past few decades, GDM rates have risen in the same trend as the rates of obesity and type 2 diabetes mellitus. A number of factors increase the risk for developing GDM. These include older maternal age (>30 years); body mass index (BMI) >25; past history of GDM; a first-degree relative with diabetes; and women of Hispanic, African American, Native American, South or East Asian, or Pacific Island descent. GDM poses risks to both the mother and baby. Pregnant women with GDM are at increased risk for preeclampsia and caesarean section. Infants are at risk for fetal macrosomia (which can cause shoulder dystocia and birth injury), and neonatal hypoglycemia. GDM also predisposes the infant to childhood obesity, and the mother to development of type 2 diabetes. Obese women with GDM carry an even greater risk for adverse outcomes during pregnancy, compared with either GDM or obesity alone. Medical nutrition therapy (MNT) and physical activity are the first-line treatment of GDM. In some women, pharmacologic therapy may be added. The goal of MNT is to encourage a healthful diet to achieve and maintain normoglycemia and promote appropriate pregnancy weight gain and adequate fetal growth. Frequent glucose monitoring and ketone testing are recommended to provide feedback about day-to-day control and to make treatment adjustments. Efforts are aimed at reducing perinatal and postpartum complications. During 2008, the Academy of Nutrition and Dietetics (Academy) published its first GDM Evidence-Based Nutrition Practice Guideline (EBNPG) on the Evidence Analysis Library (EAL) online (www.andeal.org). According to the Academy, “EBNPGs are a series of guiding statements that are developed using a systematic process for identifying, analyzing, and synthesizing scientific evidence.” EBNPGs provide timely and comprehensive guidance to assist registered dietitian nutritionists (RDNs) in decisions about appropriate nutrition care for their patients. During 2013, a new evidence analysis work group was formed to update the original EBNPG and was subsequently published as part of the EAL during January 2017. This publication outlines the methods used to complete the systematic review (SR) and guideline and examines the guideline recommendations and supporting evidence. The GDM EBNPG provides the latest, evidence-based summary of effective practice in the nutrition management of women with GDM. Principal areas

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jand.2018.03.014

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 110

Metadata

Authors
Duarte-Gardea, M. O., Gonzales-Pacheco, D. M., Reader, D. M., Thomas, A. M., Wang, S. R., Gregory, R. P., Piemonte, T. A., Thompson, K. L., & Moloney, L.
Venue
Journal of the Academy of Nutrition and Dietetics
Publisher
Elsevier BV
Published
2018-09
Volume
118
Issue
9
Pages
1719-1742
ISSN
2212-2672 (ISSN-L)
OpenAlex
W2807000538
Cited by
110
References
15
FWCI
8.21
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.